Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Nov 15, 2022; 14(11): 2170-2182
Published online Nov 15, 2022. doi: 10.4251/wjgo.v14.i11.2170
Published online Nov 15, 2022. doi: 10.4251/wjgo.v14.i11.2170
Figure 7 MiR-30e-3p inhibits gastric cancer cells growth in vivo.
A: BGC-823 cells were transfected with NC, miR-30e-3p mimic and injected subcutaneously into BALB/c nude mice. Sixteen days later, the tumors diameter were analyzed. n = 5 for each group; B: The tumor volume (mm3) was measured after the tumor implantation every other day; C: Sixteen days after the tumor implantation, the tumor weight (g) was measured; D: Sixteen days after the tumor implantation, the relative protein expression of THOC2, PI3K, AKT and mTOR was detected by Western blot. aP < 0.05, bP < 0.01.
- Citation: Gu XJ, Li YJ, Wang F, Ye T. MiR-30e-3p inhibits gastric cancer development by negatively regulating THO complex 2 and PI3K/AKT/mTOR signaling. World J Gastrointest Oncol 2022; 14(11): 2170-2182
- URL: https://www.wjgnet.com/1948-5204/full/v14/i11/2170.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i11.2170